Originalkatalog | Verfügbarkeit prüfen

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

Adès, L., Thomas, X., Bresler, A.G., Raffoux, E., Spertini, O., Vey, N., Marchand, T., Récher, C., Pigneux, A., Girault, S., Deconinck, E., Gardin, C., Tournilhac, O., Lambert, J.F., Chevallier, P., de Botton, S., Lejeune, J., Dombret, H., Chevret, S., Fenaux, P.
2018

Originalkatalog | Verfügbarkeit prüfen

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group

Lionel Adès, Xavier Thomas, Agnes Guerci Bresler, Emmanuel Raffoux, Olivier Spertini, Norbert Vey, Tony Marchand, Christian Récher, Arnaud Pigneux, Stephane Girault, Eric Deconinck, Claude Gardin, Olivier Tournilhac, Jean Francois Lambert, Patrice Chevallier, Stephane de Botton, Julie Lejeune, Hervé Dombret, Sylvie Chevret, Pierre Fenaux
Veröffentlicht in: Haematologica, Vol 103, Iss 12 (2018);
2018